
中东和非洲良性前列腺增生设备市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品(电切镜、泌尿科激光、射频消融设备、前列腺支架和植入物)、手术类型(经尿道微波治疗) 、经尿道前列腺切除术、经尿道前列腺针消融术、激光手术、Urolift 手术等)和最终用户(医院、诊所、门诊手术中心等)
No. of Pages: 126 | Report Code: BMIRE00027178 | Category: Life Sciences
No. of Pages: 126 | Report Code: BMIRE00027178 | Category: Life Sciences
中东和印度的良性前列腺增生器械市场非洲预计将从2022年的9128万美元增长到2028年的1.3044亿美元;预计 2022 年至 2028 年复合年增长率为 6.1%。
良性前列腺增生设备市场的领先企业专注于扩大客户范围通过扩大分销网络和增强制造能力,跨越该地区的新兴市场。此外,新兴国家对生命科学和医疗保健研究的高投入对于发展中国家最新技术的升级也发挥着至关重要的作用。中东和非洲地区重要的良性前列腺增生设备制造商由于非洲患者群体庞大、良性前列腺增生患病率高、可支配收入增加、医疗基础设施改善以及多个国家不断增长的医疗旅游业,预计非洲未来将出现利润丰厚的机会。
借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动中东和中东地区的发展。非洲良性前列腺增生设备市场在预测期内复合年增长率可观。
中东和非洲非洲良性前列腺增生装置市场收入及预测至 2028 年(百万美元)
中东和中东地区非洲良性前列腺增生器械市场细分
中东和非洲非洲良性前列腺增生设备市场根据产品、手术类型、最终用户和国家进行细分。根据产品,市场分为电切镜、泌尿外科激光器、射频消融设备、前列腺支架和植入物。电切镜细分市场预计将在 2022 年占据最大的市场份额。另一方面,泌尿外科激光细分市场预计在预测期内复合年增长率最高。根据程序类型,中东和非洲非洲良性前列腺增生器械市场细分为经尿道微波治疗、经尿道前列腺切除术、经尿道前列腺针消融术、激光手术、尿提升手术等。经尿道前列腺切除术在 2022 年占据最大的市场份额,预计在预测期内也将实现最高的市场复合年增长率。基于最终用户,中东和非洲地区非洲良性前列腺增生设备市场分为医院、诊所、门诊手术中心等。医院细分市场在 2022 年占据最大的市场份额,而诊所细分市场预计在预测期内复合年增长率最高。基于国家、中东和地区非洲良性前列腺增生设备市场分为沙特阿拉伯、南非、阿联酋和中东和非洲其他地区。 2022年,沙特阿拉伯占据了更大的市场份额。另一方面,预计阿联酋在预测期内将实现更高的复合年增长率。
KARL STORZ SE &两合公司;奥林巴斯公司;波士顿科学公司;泰利福公司;蝴蝶;和 ProArc 是中东地区的领先公司之一。非洲良性前列腺增生器械市场。
Strategic insights for Middle East & Africa Benign Prostatic Hyperplasic Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 91.28 Million |
Market Size by 2028 | US$ 130.44 Million |
Global CAGR (2022 - 2028) | 6.1% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East & Africa Benign Prostatic Hyperplasic Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Benign Prostatic Hyperplasic Devices Market is valued at US$ 91.28 Million in 2022, it is projected to reach US$ 130.44 Million by 2028.
As per our report Middle East & Africa Benign Prostatic Hyperplasic Devices Market, the market size is valued at US$ 91.28 Million in 2022, projecting it to reach US$ 130.44 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The Middle East & Africa Benign Prostatic Hyperplasic Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Benign Prostatic Hyperplasic Devices Market report:
The Middle East & Africa Benign Prostatic Hyperplasic Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Benign Prostatic Hyperplasic Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Benign Prostatic Hyperplasic Devices Market value chain can benefit from the information contained in a comprehensive market report.